Pacira BioSciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Pacira BioSciences Inc: Is Infosys Ltd. worth buying?
Item: Pacira BioSciences Inc
Rating: 2.286013875
Author: Trendlyne DVM scores

Mid-range Performer

about

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EX...

22.69 -0.57 (-2.45%)

948.2K

XNAS Volume

XNAS 16 Mar, 2026 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Affordable Valuation

53.8 / 100

Technically Neutral

51.3 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 28%

7 analysts

Pacira BioSciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Pacira BioSciences Inc Live Stock Price Today, Share Analysis and Chart

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EX...

SWOT Analysis

Pacira BioSciences Inc Live Price Chart